Mild hyperphosphatemia and mortality in hemodialysis patients

American Journal of Kidney Diseases

Volumn 46, Issue 1, 2005, Pages 68-77

  Rodriguez Benot, Alberto ^a   Martin Malo, Alejandro ^a   Alvarez Lara, M Antonia ^a   Rodriguez, Mariano ^a   Aljama, Pedro ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Hyperphosphatemia; Long term hemodialysis (HD); Mortality

Indexed keywords

ALBUMIN; CALCIUM; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HYPERPHOSPHATEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PROTEIN DEGRADATION; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SURVIVAL RATE;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MORTALITY; PHOSPHATES; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 20544471130     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.04.006     Document Type: Article

References (19)

1. G.A. Block, T. Hulbert-Shearon, N.W. Levin, F.K. Port Association of serum phosphate with mortality risk in chronic hemodialysis patients A national study Am J Kidney Dis 31 1998 607 617
2. S.K. Ganesh, A.G. Stack, N.W. Levin Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2001 2131 2138
3. S. Jono, M.D. McKee, C.E. Murry Phosphate regulation of vascular smooth muscle cell calcification Circ Res 87 2000 E10 E17
4. K. Amann, M.L. Gross, G.M. London, E. Ritz Hyperphosphataemia - A silent killer of patients with renal failure? Nephrol Dial Transplant 14 1999 2085-2075
5. M.P. Marco, L. Craver, A. Betriu Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population Kidney Int Suppl 85 2003 S111 S114
6. G.A. Block, P.S. Klassen, J.M. Lazarus Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2004 2208 2218
7. National Kidney Foundation K/DOQI Clinical Practice Guidelines: Bone Metabolism and Disease in Chronic Kidney Disease. Guideline 3: Evaluation of serum phosphorus levels Am J Kidney Dis 42 suppl 3 2003 S62 S63
8. J.T. Daugirdas Second generation logarithmic estimates of single-pool variable volume Kt/V An analysis of error J Am Soc Nephrol 4 1993 1205 1213
9. M.H. Zweig, G. Campbell Receiver-operating characteristic (ROC) plots A fundamental evaluation tool in clinical medicine Clin Chem 39 1993 561 577
10. E.G. Lowrie, N.L. Lew Death risk in hemodialysis patients The predictive value of commonly measured variables and an evaluation of death rate differences between facilities Am J Kidney Dis 15 1990 458 482
11. D.A. Goodkin, J.L. Bragg-Gresham, K.G. Koenig Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States The Dialysis Outcomes and Practice Patterns Study (DOPPS) J Am Soc Nephrol 14 2003 3270 3277
12. T.B. Pifer, K.P. McCullough, F.K. Port Mortality risk in hemodialysis patients and changes in nutritional indicators DOPPS Kidney Int 62 2002 2238 2245
13. G.A. Block Prevalence and clinical consequences of elevated Ca × P product in hemodialysis patients Clin Nephrol 54 2000 318 324
14. W.G. Goodman, J. Goldin, B.D. Kuizon Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 2000 1478 1483
15. W.G. Goodman Vascular calcification in chronic renal failure Lancet 358 2001 1115 1116
16. J.M. Cruz, L. Piera, J.L. Bragg-Gresham Results of the international hemodialysis study DOPPS in Spain and Europe Nefrologia 23 2003 437 443
17. S. Jono, C. Peinado, C.M. Giachelli Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification J Biol Chem 275 2000 20197 20203
18. B.A. Cooper, E.L. Penne, L.H. Bartlett, C.A. Pollock Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD Am J Kidney Dis 43 2004 61 66
19. V. Lorenzo, M. Martin, M. Rufino Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients Am J Kidney Dis 37 2001 1260 1266